Webinar | September 25, 2024
2:30 p.m. – 3:30 p.m. EDT
Register here.
Earlier this week, the FDIC proposed rules related to FDIC pass-through insurance coverage. These rules could have a significant impact on bank-fintech partnerships, including some partnerships for programs that do not promise FDIC coverage to end customers. This webinar will analyze…
September 4, 2024
9:00am – 5:00pm ET
Practising Law Insitutue (PLI) will host the 10th Annual Alternative Finance Summit: Fintech, Blockchain, and Crowdfunding program.
Mayer Brown partner Anna Pinedo will participate in a discussion on the “Securities Offering and Private Placement Developments” panel.
See the event webpage for information on the program and the session.
Webinar | July 22, 2024
1:00 p.m. – 2:00 p.m. EDT
Register here.
Disclosures by public companies about their human capital management continue to be a focus of investors, regulators, and other stakeholders. In 2020, the SEC adopted a requirement for registrants to discuss their human capital resources to the extent material to an…
Webinar | July 22, 2024
12:00 p.m. – 1:00 p.m. EDT
Register here.
The Supreme Court’s term included some of the most consequential administrative law decisions in decades. Chief among them is Loper Bright, which overruled Chevron, the decision that required federal courts to defer to administrative agencies’ interpretations of ambiguous statutes.
Webinar | June 27, 2024
1:00 – 2:00 pm ET
Register here.
The SEC adopted amendments aimed at enhancing and standardizing disclosures related to cybersecurity risks and incidents. But how is this impacting SEC registrants and how are they addressing cyber incidents within the new framework?
Join us for an overview and discussion on…
Webinar | May 21, 2024
9:00 a.m. – 9:30 a.m. EDT
Register here.
Mayer Brown’s Capital Markets and Financial Services Regulatory Team cordially invites you to our 30-minute Know-How Webinars. Over the course of this series, we will report on the main 2024 developments relevant to capital markets, structured products, derivatives, and financial regulatory…
Webinar | May 2, 2024
12:00 p.m. – 1:00 p.m. EDT
Register here.
For life sciences companies, reverse merger transactions have become increasingly popular. However, merging into a public life sciences company that has experienced a failed clinical program often raises heightened SEC scrutiny and raises legal considerations. During this session, we will discuss:…
April 15, 2024
9:00 a.m. – 5:30 pm EDT
This program, hosted by PLI and chaired by Mayer Brown partner, Eddie Best, provides a comprehensive discussion of special purpose acquisition companies (“SPACs”) with a focus on key business, legal, SEC reporting and accounting developments and considerations in each phase of the SPAC’s finite, fast-paced life…
